Biomaterial Database

Sudden idiopathic sensorineural hearing loss. 1994

J L Krupala, and R G Amedee

Tulane University Medical School, Dept of Otolaryngology, New Orleans.

Sudden loss of hearing can be a very frightening experience for the patient and frustrating for the physician. The etiology is often difficult to identify and several theories have been proposed to explain sudden "idiopathic" sensorineural hearing loss. These theories include the viral theory, the vascular theory, and the membrane rupture theory. As the etiology is uncertain, many treatment modalities have been proposed. Steroids are the only effective medical treatment to date. Surgery may be employed when evidence of perilymphatic fistula exists. Controlled studies are needed to determine the effectiveness of proposed treatment modalities.

UI	MeSH Term	Description	Entries
D007759	Labyrinth Diseases	Pathological processes of the inner ear (LABYRINTH) which contains the essential apparatus of hearing (COCHLEA) and balance (SEMICIRCULAR CANALS).	Inner Ear Disease,Ear Disease, Inner,Ear Diseases, Inner,Inner Ear Diseases,Labyrinth Disease
D011379	Prognosis	A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations.	Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D012141	Respiratory Tract Infections	Invasion of the host RESPIRATORY SYSTEM by microorganisms, usually leading to pathological processes or diseases.	Respiratory System Infections,Upper Respiratory Tract Infection,Upper Respiratory Tract Infections,Infections, Respiratory,Infections, Respiratory Tract,Infections, Upper Respiratory,Infections, Upper Respiratory Tract,Respiratory Infections,Upper Respiratory Infections,Infection, Respiratory System,Infection, Respiratory Tract,Respiratory Infection, Upper,Respiratory System Infection,Respiratory Tract Infection
D002986	Clinical Trials as Topic	Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries.	Clinical Trial as Topic
D006319	Hearing Loss, Sensorineural	Hearing loss resulting from damage to the COCHLEA and the sensorineural elements which lie internally beyond the oval and round windows. These elements include the AUDITORY NERVE and its connections in the BRAINSTEM.	Deafness Neurosensory,Deafness, Neurosensory,Deafness, Sensoryneural,Neurosensory Deafness,Sensorineural Hearing Loss,Sensoryneural Deafness,Cochlear Hearing Loss,Hearing Loss, Cochlear,Deafnesses, Neurosensory,Deafnesses, Sensoryneural,Neurosensory Deafnesses,Sensoryneural Deafness,Sensoryneural Deafnesses
D006801	Humans	Members of the species Homo sapiens.	Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818	Animals	Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA.	Animal,Metazoa,Animalia
D014652	Vascular Diseases	Pathological processes involving any of the BLOOD VESSELS in the cardiac or peripheral circulation. They include diseases of ARTERIES; VEINS; and rest of the vasculature system in the body.	Disease, Vascular,Diseases, Vascular,Vascular Disease
D015994	Incidence	The number of new cases of a given disease during a given period in a specified population. It also is used for the rate at which new events occur in a defined population. It is differentiated from PREVALENCE, which refers to all cases in the population at a given time.	Attack Rate,Cumulative Incidence,Incidence Proportion,Incidence Rate,Person-time Rate,Secondary Attack Rate,Attack Rate, Secondary,Attack Rates,Cumulative Incidences,Incidence Proportions,Incidence Rates,Incidence, Cumulative,Incidences,Person time Rate,Person-time Rates,Proportion, Incidence,Rate, Attack,Rate, Incidence,Rate, Person-time,Rate, Secondary Attack,Secondary Attack Rates

Related Publications

J L Krupala, and R G Amedee

Idiopathic sudden sensorineural hearing loss.

January 2001, Journal of the Medical Association of Thailand = Chotmaihet thangphaet,

J L Krupala, and R G Amedee

Idiopathic sudden sensorineural hearing loss.

May 1989, The American journal of otology,

J L Krupala, and R G Amedee

Treatment of idiopathic sudden sensorineural hearing loss.

July 2006, Acta oto-laryngologica,

J L Krupala, and R G Amedee

Idiopathic sudden sensorineural hearing loss in children.

June 2005, International journal of pediatric otorhinolaryngology,

J L Krupala, and R G Amedee

Is Idiopathic Sudden Sensorineural Hearing Loss Seasonal?

October 2022, Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology,

J L Krupala, and R G Amedee

Clinical practice. Idiopathic sudden sensorineural hearing loss.

August 2008, The New England journal of medicine,

J L Krupala, and R G Amedee

Steroids for idiopathic sudden sensorineural hearing loss.

July 2013, The Cochrane database of systematic reviews,

J L Krupala, and R G Amedee

Steroids for idiopathic sudden sensorineural hearing loss.

January 2006, The Cochrane database of systematic reviews,

J L Krupala, and R G Amedee

Idiopathic sudden sensorineural hearing loss in Japan.

November 2014, Acta oto-laryngologica,